We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





World's First Confirmed Case of COVID-19 Re-Infection Raises Questions Over Coronavirus Immunity

By HospiMedica International staff writers
Posted on 27 Aug 2020
Researchers have reported the world’s first confirmed case of COVID-19 re-infection, raising questions about the durability of immune protection from the SARS-CoV-2 virus.

Researchers have confirmed that a 33-year-old man was first infected by SARS-CoV-2 in late March and then again contracted the virus after four and a half months while traveling in Europe, according to a report by STAT. More...
There have been reports earlier of cases of COVID-19 re-infection, although they were based on anecdotal evidence and had been attributed mainly to flaws in testing. However, in this latest case of COVID-19 re-infection, researchers from the University of Hong Kong (Hong Kong) sequenced the virus from the patient’s two infections and found that they did not match, indicating that the second infection was not linked to the first. The researchers found a difference of 24 nucleotides, the “letters” that make up the virus’ RNA, between the two infections.

The finding of the world’s first confirmed case of COVID-19 re-infection comes amidst concerns over how long one can remain protected from the SARS-CoV-2 virus after being infected and recovering. Various studies have found that the majority of recovered COVID-19 patients generate a robust immune response involving both antibodies (molecules that can block the virus from infecting cells again) and T cells (which can help clear the virus), according to the STAT report. This indicates protection from repeat COVID-19 infection could last for some time. However, experts believe that immunity to SARS-CoV-2 cannot last forever as people generally once again become susceptible to the coronaviruses that cause common cold after a year or even less, and remain protected against SARS-1 and MERS for just a few years.

Nevertheless, experts believe that the Hong Kong case is rare and unprecedented among the tens of millions of cases globally and immune protection to COVID-19 may generally last more than a few months. More definitive conclusions could be reached only after the conclusion of studies currently tracking patients who have recovered from COVID-19. Additionally, experts have pointed out that that the Hong Kong man’s second case was milder than his first, indicating that his immune system was providing some protection against the SARS-CoV-2 virus, even if it failed to prevent re-infection entirely, according to STAT.

“There’s been more than 24 million cases reported to date,” Maria Van Kerkhove, a coronavirus expert at the World Health Organization, said at a briefing, when asked about the Hong Kong report. “And we need to look at something like this at a population level. What we are learning about infection is that people do develop an immune response, and what is not completely clear yet is how strong that immune response is and for how long that immune response lasts.”

Related Links:
University of Hong Kong


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Immobilization System
Cranial 4Pi Immobilization
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.